Filing Flows › Pacific Biosciences of California (PACB) › Q3 2026
Pacific Biosciences of California (PACB) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Pacific Biosciences of California (PACB) reported revenue of $40.6M for the third quarter 2026 (Q3 2026), +6% from a year earlier and +4% from the quarter before. Operating margin was -91.2%, net loss $37.8M (93.3% of revenue).
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40.6M | +4% | +6% |
| Operating profit | −$37.0M | — | — |
| Net earnings | −$37.8M | — | — |
| Operating cash flow | −$37.6M | — | — |
What changed
Revenue was $40.6M in Q3 2026, up 6% year over year and up 4% from the previous quarter. Consumables revenue was the largest line at 51% of revenue. Instrument revenue added $1.9M year over year (up 16%), 88% of the total change. Consumables revenue declined 2%.
Gross margin was 33.2%, down 8.2 points from Q3 2025. Operating costs exceeded revenue by $37.0M, an operating margin of -91.2%. Operating expenses fell 8% while revenue rose 6%. The quarter ended with a net loss of $37.8M, narrower than the previous quarter's $44.7M loss.
Operating cash flow was −$37.6M. Non-cash charges added back $2.5M of depreciation and $8.5M of share-based compensation. Working capital and other items used $10.8M. Capital expenditures of $1.0M exceeded it, leaving free cash flow of −$38.6M.
Questions
What was Pacific Biosciences of California's revenue in the third quarter 2026?
Pacific Biosciences of California (PACB) reported revenue of $40.6M for the third quarter 2026 (Q3 2026), +6% from a year earlier and +4% from the quarter before.
Was Pacific Biosciences of California profitable in the third quarter 2026?
Operating loss was $37.0M (-91.2% of revenue) and net loss $37.8M.
Source: Pacific Biosciences of California 10-Q on SEC EDGAR.